Evotec SE · ISIN: DE0005664809 · Directors Dealings
Insider Transaction Snapshot

Evotec SE

Directors Dealings: 1st October 2024
Reporting obligation triggered by: Rouxel, Laetitia
Trading volume: 58.396,84 EUR
Type: not specified

The Insider Transaction was made by Rouxel, Laetitia . The transaction toke place on 1st October 2024. The order was executed at the trading place XETRA. The aggregated volume was 58.396,84 EUR, based on an average price of 6,39 EUR. The nature of the Investment was not specified.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
New DD.i/o
06 December 2023
Fresenius Medical Care AG: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 6th December 2023,

The Insider Transaction was made by Valle, William . The transaction toke place on 4th December 2023. . The aggregated volume was 366.225,00 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.

Fresenius Medical Care AG
06 December 2023
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 6th December 2023,

The Insider Transaction was made by Valle, William . The transaction toke place on 4th December 2023. . The aggregated volume was 366.225,00 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.

Fresenius Medical Care AG & Co. KGaA
16 December 2022
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th December 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 15th December 2022,

The Insider Transaction was made by Valle, William . The transaction toke place on 14th December 2022. The order was executed at the trading place NYSE. . The aggregated volume was 53.533,54 USD, based on an average price of 16,25 USD. The nature of the Investment was Buy.

Fresenius Medical Care AG & Co. KGaA
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html